Answers are grounded in this paper and cite their sources.
Objective To investigate the expression and prognosis significance of zinc-finger E-box binding homeobox 2 (ZEB2) and transforming growth factor β1(TGF-β1) in epithelial ovarian cancer. Methods Immunohistochemistry SP method was adopted to detect the expression of ZEB2 and TGF-β1 in 52 specimens of epithelial ovarian cancer, 23 cases of benign ovarian tumor, and 15 cases of normal ovarian tissue.In patients with epithelial ovarian cancer, the relationship among the expression of ZEB2, the expression of TGF-β1, the clinical and pathological characteristics and the prognosis were then evaluated. Results ZEB2 and TGF-β1 in epithelial ovarian cancer, benign epithelial ovarian tumor and normal ovarian tissue were both located in cytoplasm, and the positive expression rate of ZEB2 and TGF-β1 were 67.3%, 21.7%, 13.3%(χ2=21.340, P 0.05). The overall survival rate of epithelial ovarian cancer patients was related to the expression of ZEB2 and TGF-β1(P<0.05). Multivariate COX regression revealed that the positive expression of ZEB2 was a risk factor for the prognosis of epithelial ovarian cancer(OR=2.653, P<0.05). Conclusion ZEB2 and TGF-β1 proteins may promote the development of epithelial ovarian cancer, and ZEB2 may be a new indicator to predict the prognosis.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: